These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis using 4-Fr pancreatic plastic stents placed with common-type guidewires: Results from a prospective multinational registry. Sahar N; Ross A; Lakhtakia S; Coté GA; Neuhaus H; Bruno MJ; Haluszka O; Kozarek R; Ramchandani M; Beyna T; Poley JW; Maranki J; Freeman M; Kedia P; Tarnasky P; Dig Endosc; 2019 May; 31(3):299-306. PubMed ID: 30506606 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population. Troendle DM; Abraham O; Huang R; Barth BA Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation: a prospective randomized trial. Conigliaro R; Manta R; Bertani H; Manno M; Barbera C; Caruso A; Olivetti G; Melotti G; Frazzoni M Surg Endosc; 2013 Feb; 27(2):569-74. PubMed ID: 22926890 [TBL] [Abstract][Full Text] [Related]
11. Need for pancreatic stenting after sphincterotomy in patients with difficult cannulation. Nakahara K; Okuse C; Suetani K; Michikawa Y; Kobayashi S; Otsubo T; Itoh F World J Gastroenterol; 2014 Jul; 20(26):8617-23. PubMed ID: 25024617 [TBL] [Abstract][Full Text] [Related]
12. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis. Chahal P; Tarnasky PR; Petersen BT; Topazian MD; Levy MJ; Gostout CJ; Baron TH Clin Gastroenterol Hepatol; 2009 Aug; 7(8):834-9. PubMed ID: 19447196 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate. Pahk A; Rigaux J; Poreddy V; Smith J; Al-Kawas F Dig Dis Sci; 2011 Oct; 56(10):3058-64. PubMed ID: 21487771 [TBL] [Abstract][Full Text] [Related]
14. Small prophylactic pancreatic duct stents: an assessment of spontaneous passage and stent-induced ductal abnormalities. Lawrence C; Cotton PB; Romagnuolo J; Payne KM; Rawls E; Hawes RH Endoscopy; 2007 Dec; 39(12):1082-5. PubMed ID: 17886200 [TBL] [Abstract][Full Text] [Related]
15. Risk factors of post-ERCP pancreatitis in high-risk patients despite prevention with prophylactic pancreatic stents. Dubravcsik Z; Hritz I; Szepes A; Madácsy L Scand J Gastroenterol; 2020 Jan; 55(1):95-99. PubMed ID: 31852319 [No Abstract] [Full Text] [Related]
16. 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis. Afghani E; Akshintala VS; Khashab MA; Law JK; Hutfless SM; Kim KJ; Lennon AM; Kalloo AN; Singh VK Endoscopy; 2014 Jul; 46(7):573-80. PubMed ID: 24830399 [TBL] [Abstract][Full Text] [Related]
17. Is there any difference in outcomes between long pigtail and short flanged prophylactic pancreatic duct stents? Iqbal S; Shah S; Dhar V; Stavropoulos SN; Stevens PD Dig Dis Sci; 2011 Jan; 56(1):260-5. PubMed ID: 20464492 [TBL] [Abstract][Full Text] [Related]